NeueHealth Valuation
| NEUE Stock | 5.00 0.07 1.38% |
At this time, the firm appears to be undervalued. NeueHealth secures a last-minute Real Value of USD9.66 per share. The latest price of the firm is USD5.0. Our model forecasts the value of NeueHealth from analyzing the firm fundamentals such as Profit Margin of (0.99) %, current valuation of 1.37 B, and Return On Equity of -1.83 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting NeueHealth's valuation include:
Enterprise Value 1.4 B |
Undervalued
Today
Please note that NeueHealth's price fluctuation is somewhat reliable at this time. Calculation of the real value of NeueHealth is based on 3 months time horizon. Increasing NeueHealth's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NeueHealth stock is determined by what a typical buyer is willing to pay for full or partial control of NeueHealth. Since NeueHealth is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NeueHealth Stock. However, NeueHealth's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0 | Real 9.66 | Target 24.33 | Hype 4.99 | Naive 5.29 |
The real value of NeueHealth Stock, also known as its intrinsic value, is the underlying worth of NeueHealth Company, which is reflected in its stock price. It is based on NeueHealth's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NeueHealth's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NeueHealth helps investors to forecast how NeueHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NeueHealth more accurately as focusing exclusively on NeueHealth's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use NeueHealth's intrinsic value based on its ongoing forecasts of NeueHealth's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against NeueHealth's closest peers. If more than one evaluation category is relevant for NeueHealth we suggest using both methods to arrive at a better estimate.
NeueHealth Cash |
|
NeueHealth Valuation Trend
Comparing NeueHealth's enterprise value against its market capitalization is a good way to estimate the value of NeueHealth uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
NeueHealth Revenue by Product
NeueHealth Total Value Analysis
NeueHealth is now anticipated to have valuation of 1.37 B with market capitalization of 52.8 M, debt of 370.35 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the NeueHealth fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.37 B | 52.8 M | 370.35 M |
NeueHealth Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. NeueHealth has an asset utilization ratio of 94.72 percent. This indicates that the Company is making USD0.95 for each dollar of assets. An increasing asset utilization means that NeueHealth is more efficient with each dollar of assets it utilizes for everyday operations.NeueHealth Ownership Allocation
The market capitalization of NeueHealth is USD52.8 Million. Over half of NeueHealth's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.NeueHealth Profitability Analysis
The company reported the previous year's revenue of 1.16 B. Net Loss for the year was (1.15 B) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates NeueHealth's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in NeueHealth and how it compares across the competition.
About NeueHealth Valuation
The stock valuation mechanism determines NeueHealth's current worth on a weekly basis. Our valuation model uses a comparative analysis of NeueHealth. We calculate exposure to NeueHealth's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NeueHealth's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 164.2 M | 130.4 M | |
| Pretax Profit Margin | (0.54) | (0.57) | |
| Operating Profit Margin | (0.50) | (0.52) | |
| Net Loss | (0.99) | (1.04) | |
| Gross Profit Margin | 0.14 | 0.10 |
NeueHealth Growth Indicators
Investing in growth stocks can be very risky. If the company such as NeueHealth does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 8 M |
NeueHealth Current Valuation Indicators
Valuation refers to the process of determining the present value of NeueHealth and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NeueHealth we look at many different elements of the entity such as NeueHealth's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NeueHealth, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NeueHealth's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NeueHealth's worth.Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |